ERN1 and chronic myelogenous leukemia, BCR-ABL1 positive: Recently, it was found that a new generation proteasome inhibitor oprozomib leads CML cells towards apoptosis through a synergistic effect of calcium leakage and phosphorylation of PERK and IRE1α [15].